These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23936141)

  • 1. Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer.
    Gabriel K; Ingram A; Austin R; Kapoor A; Tang D; Majeed F; Qureshi T; Al-Nedawi K
    PLoS One; 2013; 8(7):e70047. PubMed ID: 23936141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
    Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer.
    Lu H; Bowler N; Harshyne LA; Craig Hooper D; Krishn SR; Kurtoglu S; Fedele C; Liu Q; Tang HY; Kossenkov AV; Kelly WK; Wang K; Kean RB; Weinreb PH; Yu L; Dutta A; Fortina P; Ertel A; Stanczak M; Forsberg F; Gabrilovich DI; Speicher DW; Altieri DC; Languino LR
    Matrix Biol; 2018 Sep; 70():20-35. PubMed ID: 29530483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
    Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
    PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of ERG expression and PTEN loss in a Brazilian prostate cancer cohort.
    Morais CE; Gurgel DC; Teixeira AC; Mattos TVA; Silva AVAD; Tavora F
    Braz J Med Biol Res; 2019; 52(12):e8483. PubMed ID: 31826177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.
    Krishn SR; Singh A; Bowler N; Duffy AN; Friedman A; Fedele C; Kurtoglu S; Tripathi SK; Wang K; Hawkins A; Sayeed A; Goswami CP; Thakur ML; Iozzo RV; Peiper SC; Kelly WK; Languino LR
    Matrix Biol; 2019 Apr; 77():41-57. PubMed ID: 30098419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer.
    Cuzick J; Yang ZH; Fisher G; Tikishvili E; Stone S; Lanchbury JS; Camacho N; Merson S; Brewer D; Cooper CS; Clark J; Berney DM; Møller H; Scardino P; Sangale Z;
    Br J Cancer; 2013 Jun; 108(12):2582-9. PubMed ID: 23695019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes.
    Lázaro-Ibáñez E; Sanz-Garcia A; Visakorpi T; Escobedo-Lucea C; Siljander P; Ayuso-Sacido A; Yliperttula M
    Prostate; 2014 Oct; 74(14):1379-90. PubMed ID: 25111183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
    Kawakami K; Fujita Y; Matsuda Y; Arai T; Horie K; Kameyama K; Kato T; Masunaga K; Kasuya Y; Tanaka M; Mizutani K; Deguchi T; Ito M
    BMC Cancer; 2017 May; 17(1):316. PubMed ID: 28476099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.
    Zhang L; Zhang S; Yao J; Lowery FJ; Zhang Q; Huang WC; Li P; Li M; Wang X; Zhang C; Wang H; Ellis K; Cheerathodi M; McCarty JH; Palmieri D; Saunus J; Lakhani S; Huang S; Sahin AA; Aldape KD; Steeg PS; Yu D
    Nature; 2015 Nov; 527(7576):100-104. PubMed ID: 26479035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN Loss in a Prostate Cancer Cohort From Jordan.
    Al Bashir S; Alzoubi A; Alfaqih MA; Kheirallah K; Smairat A; Haddad H; Al-Dwairy A; Fawwaz BAB; Alzoubi M; Trpkov K
    Appl Immunohistochem Mol Morphol; 2020; 28(5):389-394. PubMed ID: 30614821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferred by exosomes-derived MiR-19b-3p targets PTEN to regulate esophageal cancer cell apoptosis, migration and invasion.
    Zeng Q; Zhu Z; Song L; He Z
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN.
    Sun S; Chen H; Xu C; Zhang Y; Zhang Q; Chen L; Ding Q; Deng Z
    Life Sci; 2020 Mar; 244():117297. PubMed ID: 31954745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma.
    Wang X; Wang X; Zhu Z; Li W; Yu G; Jia Z; Wang X
    Biomed Pharmacother; 2019 Sep; 117():109109. PubMed ID: 31229922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
    Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
    Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.
    McKiernan J; Donovan MJ; O'Neill V; Bentink S; Noerholm M; Belzer S; Skog J; Kattan MW; Partin A; Andriole G; Brown G; Wei JT; Thompson IM; Carroll P
    JAMA Oncol; 2016 Jul; 2(7):882-9. PubMed ID: 27032035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.
    Bhagirath D; Yang TL; Bucay N; Sekhon K; Majid S; Shahryari V; Dahiya R; Tanaka Y; Saini S
    Cancer Res; 2018 Apr; 78(7):1833-1844. PubMed ID: 29437039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery.
    Li M; Rai AJ; DeCastro GJ; Zeringer E; Barta T; Magdaleno S; Setterquist R; Vlassov AV
    Methods; 2015 Oct; 87():26-30. PubMed ID: 25814440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
    Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W
    Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers.
    Burdelski C; Bujupi E; Tsourlakis MC; Hube-Magg C; Kluth M; Melling N; Lebok P; Minner S; Koop C; Graefen M; Heinzer H; Wittmer C; Sauter G; Wilczak W; Simon R; Schlomm T; Steurer S; Krech T
    PLoS One; 2015; 10(6):e0128525. PubMed ID: 26030748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.